These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 10845668)
21. Insulin resistance-associated hepatic iron overload. Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879 [TBL] [Abstract][Full Text] [Related]
22. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis. Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559 [TBL] [Abstract][Full Text] [Related]
23. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703 [TBL] [Abstract][Full Text] [Related]
24. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy. Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761 [TBL] [Abstract][Full Text] [Related]
25. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318 [TBL] [Abstract][Full Text] [Related]
26. Mutations of the HFE gene in patients with hepatocellular carcinoma. Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066 [TBL] [Abstract][Full Text] [Related]
27. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population. Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971 [TBL] [Abstract][Full Text] [Related]
29. HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia. Parkkila S; Niemelä O; Savolainen ER; Koistinen P Transfusion; 2001 Jun; 41(6):828-31. PubMed ID: 11399828 [TBL] [Abstract][Full Text] [Related]
30. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Shiono Y; Ikeda R; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Imaizumi Y; Yano M; Yoshioka K; Kawanaka M; Yamada G Intern Med; 2001 Sep; 40(9):852-6. PubMed ID: 11579943 [TBL] [Abstract][Full Text] [Related]
31. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000). Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433 [TBL] [Abstract][Full Text] [Related]
32. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358 [TBL] [Abstract][Full Text] [Related]
33. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Grove J; Daly AK; Burt AD; Guzail M; James OF; Bassendine MF; Day CP Gut; 1998 Aug; 43(2):262-6. PubMed ID: 10189855 [TBL] [Abstract][Full Text] [Related]
34. Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Brandhagen DJ; Fairbanks VF; Baldus WP; Smith CI; Kruckeberg KE; Schaid DJ; Thibodeau SN Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367 [TBL] [Abstract][Full Text] [Related]
35. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. Dhillon BK; Das R; Garewal G; Chawla Y; Dhiman RK; Das A; Duseja A; Chandak GR World J Gastroenterol; 2007 Jun; 13(21):2956-9. PubMed ID: 17589946 [TBL] [Abstract][Full Text] [Related]
36. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma]. Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580 [TBL] [Abstract][Full Text] [Related]
37. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210 [TBL] [Abstract][Full Text] [Related]
38. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Wallace DF; Dooley JS; Walker AP Gastroenterology; 1999 Jun; 116(6):1409-12. PubMed ID: 10348824 [TBL] [Abstract][Full Text] [Related]
40. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred. Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Sánchez-Anzaldo J; Ruiz-Delgado GJ; Jiménez-González C; Carrera B Rev Invest Clin; 2001; 53(2):117-20. PubMed ID: 11421105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]